1. The Oral-Gut Microbial Axis
Your gut microbiome begins in the mouth—oral bacteria swallowed every day reach the intestine, where oral dysbiosis can feed inflammation far downstream.
The Mouth as the Gateway – Where the Microbiome Begins
Your gut microbiota[G] does not start in the stomach. It starts in your mouth [207].
In 1890, an American dentist named Willoughby Dayton Miller, working at the University of Berlin, published a book called 'The Microorganisms of the Human Mouth' that proposed something his contemporaries found radical: that dental caries was not caused by constitutional weakness or sugar itself but by the acid produced when oral bacteria fermented dietary carbohydrates. He called it the chemoparasitic theory of caries. It was correct. Miller's work established the oral cavity as a microbial ecosystem – a community of organisms living on and between teeth, on the tongue, and in the sulcus beneath the gum line, interacting with each other and with the host's diet in ways that determined whether the hard tissues of the teeth were preserved or destroyed. This was, in 1890, a genuinely new way of thinking about the mouth. The gut was not part of the picture at all. It took until the early twenty-first century – with the development of high-throughput sequencing and large-scale microbiome studies – to establish that the oral microbiome is not sealed from the gut, that organisms originating in the mouth are consistently detected in intestinal samples, and that oral dysbiosis is associated with intestinal inflammatory conditions in ways that suggest a route of communication Miller never imagined. The mouth he described in 1890 is the beginning of the tube, not a separate organ.
The connection between the oral microbiome[G] and systemic health was understood in medicine long before the gut microbiota era – but through a narrower lens. Streptococcus mutans and oral Streptococcus viridans were known since the early 20th century as agents of dental caries and bacterial endocarditis respectively. The broader concept that the oral cavity seeds the gut with microorganisms in a biologically meaningful way emerged much later. A pivotal demonstration came from Hajishengallis and colleagues, who published a series of papers between 2010 and 2015 showing that Porphyromonas gingivalis – the keystone pathogen of periodontitis – was not merely a local periodontal pathogen but a systemic driver of inflammation through its ability to survive transit, reach the gut, and reshape the gut microbiota toward a more inflammatory composition. [249] A 2019 study by Atarashi and colleagues published in Science extended this directly. The researchers isolated specific oral bacteria – Fusobacterium nucleatum and Klebsiella pneumoniae, both associated with periodontal disease – from patients with inflammatory bowel disease (Inflammatory Bowel Disease: Crohn's disease and ulcerative colitis), and demonstrated that these oral species colonized the gut of germ-free[G] mice and induced colitis-like inflammation. The oral microbiota was not merely cohabiting with the gut microbiota: it was contributing pathobionts that could trigger intestinal immune activation. [250] The clinical significance is that oral health is not a separate domain from gut health – it is a microbial upstream input to it. Patients with chronic periodontal disease maintain a continuous reservoir of dysbiotic oral organisms that seed the gut via swallowing, potentially contributing to or sustaining intestinal inflammation. [207] For clinical practice, this means that assessment of oral hygiene status is relevant in any patient with unexplained or refractory gastrointestinal inflammation, and that periodontal treatment should be considered part of a comprehensive gut microbiota management strategy rather than a separate dental matter.
The oral cavity is the entry point of the gastrointestinal tract and hosts one of the most diverse microbial communities in the human body – second only to the colon. Approximately 700 bacterial species have been identified in the oral microbiome, residing in distinct ecological niches: tooth surfaces, gingival crevices, tongue dorsum, buccal mucosa, tonsils, and saliva. This community is not isolated; it is continuously swallowed, introducing oral bacteria into the intestinal tract with every meal and throughout the day [249].
The oral-gut microbial axis describes the bidirectional relationship between the oral and intestinal microbiomes. Under healthy conditions, the physical and immune barriers of the gastrointestinal tract – gastric acid, bile, pancreatic enzymes, and mucosal immunity – prevent most oral bacteria from establishing in the gut. However, when these barriers are compromised, or when oral dysbiosis[G] produces bacteria in quantities that overwhelm normal clearance mechanisms, oral microorganisms reach and colonise the intestinal mucosa.
Periodontal pathogens – Porphyromonas gingivalis, Fusobacterium nucleatum, Treponema denticola, and Tannerella forsythia – are among the oral species most consistently detected in gut samples from patients with inflammatory bowel disease, colorectal cancer, and other intestinal pathologies. Fusobacterium nucleatum is now one of the most studied oral-to-gut translocation species, with direct mechanistic links to colorectal tumour microenvironment modulation.
The oral microbiome influences systemic health through multiple pathways beyond direct gut translocation. Oral bacteria enter the bloodstream during chewing, toothbrushing, dental procedures, or through inflamed gingival tissue. Bacteraemia (the presence of bacteria in the bloodstream; a rare but serious complication) (the presence of bacteria in the bloodstream) – even transient – exposes distant tissues to bacterial products and antigens, contributing to systemic immune activation and chronic low-grade inflammation. This pathway connects oral dysbiosis to cardiovascular disease, metabolic syndrome, rheumatoid arthritis, and adverse pregnancy outcomes.
Nitrate metabolism is a clinically important function of the oral microbiome. Dietary nitrates from vegetables are reduced to nitrite by oral bacteria (particularly Neisseria and Rothia species), which is then converted in the stomach to nitric oxide – a vasodilatory and antimicrobial molecule with systemic cardiovascular and gut benefits. Mouthwash use that kills oral bacteria disrupts this nitrate-nitrite-nitric oxide pathway, with measurable acute effects on blood pressure and exercise capacity.
Saliva is both a microbial habitat and a transport medium. Swallowing approximately 1.5 litres of saliva per day delivers a continuous stream of oral microorganisms into the gut. In oral dysbiosis – characterised by reduced diversity and elevated pathobiont abundance – this daily inoculation amplifies gut exposure to potentially harmful species.
Maintaining oral microbiome health is therefore not a purely dental concern. It is an integral component of systemic and gut microbiota management, particularly for patients undergoing FMT or active microbiota recovery programmes.
Supporting the Oral-Gut Axis in Clinical Practice
Oral hygiene is the primary modifiable determinant of oral microbiome composition. Consistent toothbrushing, interdental cleaning, and tongue cleaning reduce pathobiont load and support commensal oral bacterial communities, directly reducing the quality of the oral inoculum delivered to the gut daily.
Diet is a major driver of oral microbiome composition. Dietary sugar feeds acid-producing oral bacteria (Streptococcus mutans, Lactobacillus species) that drive enamel demineralisation and oral dysbiosis. Reducing sugar frequency and quantity – not only total amount but the number of daily exposure events – is among the most impactful dietary interventions for oral microbiome health.
Vegetable-derived nitrates support the oral-systemic nitrate pathway. Green leafy vegetables (rocket, spinach, beetroot, celery) are the richest dietary nitrate sources. Maintaining dietary nitrate intake preserves the substrate available to oral nitrate-reducing bacteria, supporting downstream nitric oxide production.
Antibiotic use, including topical oral antibiotics and antiseptic mouthwashes, disrupts oral microbiome diversity. Clinicians managing gut microbiota recovery consider oral antibiotic and antiseptic exposure alongside systemic antibiotic use when assessing total antimicrobial burden.
Smoking and tobacco products produce major oral dysbiosis through direct mucosal toxicity, altered immune responses, and changes in oxygen availability in the oral cavity. Smoking cessation is a high-priority intervention for oral microbiome health and its downstream gut and systemic effects.
Hydration supports salivary flow, which is a key oral microbiome maintenance mechanism. Saliva buffers oral pH, delivers antimicrobial proteins (lactoferrin, lysozyme, sIgA), and mechanically clears bacteria from oral surfaces. Chronic dehydration reduces salivary flow and contributes to oral dysbiosis.
Regular dental care – professional cleaning and periodontal assessment at least twice yearly – removes subgingival biofilm that cannot be addressed through home hygiene alone, reduces periodontal pathobiont load, and supports the oral-gut axis directly.
Microbiota Effects
- Oral dysbiosis provides a continuous source of pathobiont inoculation to the gut through daily saliva swallowing, contributing to intestinal dysbiosis particularly when gastric and immune barriers are compromised [249].
- Fusobacterium nucleatum, Porphyromonas gingivalis, and other periodontal pathogens translocate to the gut and have been detected in colorectal cancer tissue, IBD (inflammatory bowel disease: Crohn's disease and ulcerative colitis) mucosa, and liver samples, with direct mechanistic roles in tumour promotion and intestinal inflammation [39].
- The oral nitrate-nitrite-nitric oxide pathway, mediated by oral commensal bacteria, produces nitric oxide with vasodilatory, antimicrobial, and gut barrier-supportive properties – a function disrupted by antiseptic mouthwash use.
- Oral microbiome diversity is positively correlated with gut microbiota diversity in healthy individuals; restoration of oral microbiome health following periodontal treatment is associated with partial improvement in gut microbiota composition in some studies.
- Bacteraemia from oral dysbiosis activates systemic immune pathways that increase intestinal permeability[G] and mucosal inflammation indirectly, even without direct oral-to-gut bacterial translocation.
- Salivary microbial composition partially predicts gut microbiota composition, suggesting that the oral microbiome is not merely a passive upstream contributor but an active shaper of the intestinal microbial environment.
Patient Guidance
- Brush teeth twice daily with a soft-bristled toothbrush using correct technique – two minutes minimum.
- Clean between teeth daily using interdental brushes or floss.
- Clean the tongue daily with a tongue scraper or the back of a toothbrush.
- Attend professional dental cleaning and periodontal assessment at least twice per year.
- Reduce sugar frequency – limit sugary food and drink to mealtimes rather than throughout the day.
- Eat nitrate-rich vegetables daily (rocket, spinach, beetroot, celery) to support the oral-gut nitrate pathway.
- Avoid routine antiseptic mouthwash use; use only when clinically indicated and for the shortest necessary duration.
- Stay well hydrated to support salivary flow and oral microbiome maintenance.
- If you smoke, treat cessation as a priority intervention for both oral and gut microbiota health.
- Report bleeding gums, persistent bad breath, or mouth pain to your dental clinician promptly.
References
[39] Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016. Link
Mechanistic review of short-chain fatty acids (SCFAs) — a major class of bacterial metabolites derived from dietary fibre fermentation — as central mediators between diet, gut microbiota, and host physiology. SCFAs activate G-protein-coupled receptors, inhibit histone deacetylases, and serve as energy substrates, thereby influencing metabolic, immune, and epigenetic processes. The authors synthesize evidence implicating SCFA-mediated signalling in both health maintenance and disease pathogenesis. Provides the conceptual backbone for fibre-based and microbiome-directed therapeutic strategies.
[207] Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest. 2015. Link
This review summarizes preclinical evidence that the gut microbiota influences the bidirectional CNS-ENS-GI axis. Germ-free rodent studies show that microbiota shape emotional behaviour, stress- and pain-modulation systems and brain neurotransmitters. Probiotic and antibiotic perturbations modulate these endpoints in adult animals. Multiple endocrine and neurocrine pathways mediate microbiota-to-brain signalling, while the brain alters microbial composition via the autonomic nervous system. Translation of these findings to healthy humans and gut-brain axis disorders remains limited and is identified as a research priority.
[249] Atarashi K, Suda W, Luo C et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science. 2017. Link
This gnotobiotic study showed that salivary Klebsiella strains, when colonizing the gut, are strong inducers of T helper 1 (TH1) cells. These antibiotic-resistant Klebsiella strains colonize when intestinal microbiota are dysbiotic and elicit severe gut inflammation in genetically susceptible hosts. The findings establish the oral cavity as a reservoir for potential intestinal pathobionts that exacerbate disease such as IBD when ectopically colonizing the gut.
[250] Hajishengallis G, Lamont RJ. Dancing with the stars: how choreographed bacterial interactions dictate nososymbiocity and give rise to keystone pathogens, accessory pathogens, and pathobionts. Trends Microbiol. 2016. Link
This review introduces the concept of nososymbiocity-disease arising from polymicrobial communities of indigenous organisms disrupting homeostasis on mucosal surfaces. The authors describe functional designations along the commensal-pathogen spectrum, including accessory pathogens that enhance pathogen colonization, keystone pathogens or alpha-bugs that exert outsized influence at low abundance, and pathobionts that exploit disrupted homeostasis. The findings provide a framework for understanding polymicrobial synergy in chronic inflammatory mucosal diseases.